Enhanced Quality in Primary Care for Elders With Diabetes and Dementia (EQUIPED-ADRD)

NYU Langone Health

Status: Completed

Conditions: Alzheimer Disease; Diabetes; Dementia

Treatments: Behavioral: Control (CON); Behavioral: EQUIPED-ADRD Intervention

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT03723707

1R21AG057291-01 (U.S. NIH Grant/Contract)

s18-01166

Details and patient eligibility

About

The purpose of this study is to develop and test a care quality improvement intervention featuring use of consensus decisional guidance for the medical management of diabetes (DM) in patients with Alzheimer's disease and related dementia (ADRD) in primary care, provider (PCP) workflow enhancements supported by a panel manager(PM) for workflow support, electronic health record (EHR) decision support and feedback, and PCP collaborative learning.

Enrollment: 355 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient must receive care at participating NYU FGP clinics.
• Patient must be English or Spanish speaking.
• Patient must have DM diagnosis.
• Patient must have documented cognitive impairment or an ADRD diagnosis.
• Patient must have someone who is identified as a family or friend who provides caregiving assistance.

Caregiver:

• Caregiver must have adequate knowledge of identified patient and/or participate in that member's healthcare decisions.
• Caregiver must be English or Spanish speaking.
• Caregiver must demonstrate capacity to consent to research participation.
• Caregiver must be at least 21 years old.

Exclusion criteria

Patient:

• Patient does not receive care at participating NYU FGP clinics.
• Patient is not 65 years and older.
• Patient is not English or Spanish speaking.
• Patient does not have DM diagnosis.
• Patient does not have documented Cognitive impairment or an ADRD diagnosis.
• Patient has severe dementia, other terminal illness with <6 months to live, and/or is hospice eligible.
• Patient does not have a caregiver.

Caregiver:

• Caregiver does not have adequate knowledge of identified patient and/or does not participate in that member's healthcare decisions.
• Caregiver is not English or Spanish speaking.
• Caregiver lacks capacity to consent to research.
• Caregiver is under 21 years old.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

355 participants in 2 patient groups, including a placebo group

Intervention (INT)

Experimental group

Description:

(10 clinic sites and \~500 patients) which includes practice guidelines for clinicians, provider education, electronic health record support for quality DM-ADRD care, information about community/clinical resources, ongoing targeted provider feedback, and a panel manager (PM)

Treatment:

Behavioral: EQUIPED-ADRD Intervention

Control (CON)

Placebo Comparator group

Description:

During training the CON providers will be encouraged to do cognitive screening as well as follow the guidelines in general.

Treatment:

Behavioral: Control (CON)